Health Condition 1: C692- Malignant neoplasm of retina
Conditions
Interventions
Intervention1: VERSED SEDATIVE: Dose calculated based on weight of patient (0.2-0.8mg/kg)
Frequency - at each appointment of ocular prosthesis fabrication
Route of administration - intranasal
Interven
Sponsors
ANSHU BAID
Eligibility
Inclusion criteria
Inclusion criteria: Subjects aged 1-14 years of age Subjects with unilateral enucleation, evisceration or exenteration.
Exclusion criteria
Exclusion criteria: Subjects under the age of 1 year or body weight Subjects with any form of acute disease Subjects with respiratory or cardiac disease that affects daily life Subjects with neuromuscular diseases as myasthenia gravis Subjects with allergy to benzodiazepine Subjects with sleep apnoea. Subjects with liver dysfunction (dose adjustment may be necessary) Subjects with hepatic dysfunction (dose adjustment may be necessary) Subjects with porphyria
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate prosthetic outcome & ease of fabrication of ocular prosthesis in pediatric subjects with and without conscious sedation.Timepoint: At each appointment when step of ocular prosthesis fabrication is done. | — |
Secondary
| Measure | Time frame |
|---|---|
| The primary outcome is ease of fabrication of prosthesis whereas secondary outcome is time taken during ocular prosthesis fabrication, use of physical restraints during prosthesis fabrication and comparison of above parameters based on age and gender. Timepoint: To fill the pre-validated questionnaire at each appointment of ocular prosthesis fabrication | — |
Countries
India
Contacts
Public ContactANSHU BAID
KING GEORGES MEDICAL UNIVERSITY
Outcome results
None listed